Earned Wealth Advisors LLC Raises Holdings in CME Group Inc. $CME

Earned Wealth Advisors LLC boosted its stake in CME Group Inc. (NASDAQ:CMEFree Report) by 6.7% during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,377 shares of the financial services provider’s stock after buying an additional 150 shares during the quarter. Earned Wealth Advisors LLC’s holdings in CME Group were worth $655,000 as of its most recent filing with the SEC.

Other large investors have also recently bought and sold shares of the company. Wayfinding Financial LLC purchased a new stake in CME Group during the 1st quarter worth about $25,000. Webster Bank N. A. boosted its stake in shares of CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after purchasing an additional 60 shares during the last quarter. Cornerstone Planning Group LLC boosted its stake in shares of CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 55 shares during the last quarter. Highline Wealth Partners LLC lifted its stake in shares of CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 43 shares during the period. Finally, Golden State Wealth Management LLC lifted its stake in shares of CME Group by 612.5% during the first quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after buying an additional 98 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Trading Up 0.5%

NASDAQ CME opened at $262.89 on Friday. The stock has a market cap of $94.74 billion, a P/E ratio of 25.47, a PEG ratio of 4.41 and a beta of 0.41. The company’s fifty day simple moving average is $265.91 and its 200-day simple moving average is $272.01. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 52 week low of $213.94 and a 52 week high of $290.79.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The firm had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the firm earned $2.68 EPS. CME Group’s quarterly revenue was down 3.0% on a year-over-year basis. Equities research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a $1.25 dividend. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CME. The Goldman Sachs Group boosted their price target on CME Group from $262.00 to $263.00 and gave the company a “sell” rating in a report on Thursday, October 23rd. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. Piper Sandler increased their target price on CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 15th. Jefferies Financial Group decreased their price target on CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a research note on Friday, October 10th. Finally, Barclays lowered their price target on CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a report on Wednesday, October 8th. Eight investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $284.53.

Get Our Latest Stock Report on CME

Insider Transactions at CME Group

In other news, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel directly owned 7,851 shares of the company’s stock, valued at approximately $2,056,962. This represents a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William R. Shepard bought 262 shares of the company’s stock in a transaction on Thursday, September 25th. The stock was bought at an average cost of $265.19 per share, for a total transaction of $69,479.78. Following the completion of the transaction, the director directly owned 258,459 shares of the company’s stock, valued at $68,540,742.21. This trade represents a 0.10% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have sold a total of 13,043 shares of company stock valued at $3,527,956 over the last 90 days. Insiders own 0.30% of the company’s stock.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.